National medicine regulator, the Food and Drug Administration (FDA), recently approved the world's first vaccines to prevent RSV, or respiratory syncytial virus, for infants and elderly adults.
Sep 14, 2023
0
12
A nationwide rollout of the latest typhoid vaccine for all children under 15 has begun in Malawi.
Sep 12, 2023
0
1
A new COVID variant is circulating. Flu season is about to begin. Respiratory syncytial virus (known as RSV) is becoming a greater cause of hospitalizations.
Sep 6, 2023
1
24
Researchers at the University of Montana and their partners are nearing human trials for vaccines to prevent fentanyl and heroin drug overdoses.
Aug 29, 2023
1
71
With the Food and Drug Administration's Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to ...
Aug 28, 2023
0
6
Professor Bernd Rehm and Dr. Shuxiong Chen from the Griffith Institute for Drug Discovery (GRIDD) and Griffith's Center for Cell Factories and Biopolymers have succeeded in developing a new vaccine modality that is a stable ...
Aug 24, 2023
0
21
An experimental malaria vaccine appears safe and promotes an immune response in African infants, one of the groups most vulnerable to severe malaria disease.
Aug 11, 2023
0
23
Two experimental malaria vaccines are not only safe for humans, one of those immunizations prompted a slowing of the malaria parasite's replication in the bloodstream of clinical trial participants, scientists have found ...
Victoria University of Wellington's Ferrier Research Institute and the Malaghan Institute of Medical Research in New Zealand, and the Peter Doherty Institute for Infection and Immunity in Australia have developed an mRNA-based ...
Jul 20, 2023
0
62
A multi-institutional collaborative has developed a novel mRNA derivative and demonstrated its high cellular-immunity-inducing anti-cancer activities in a mouse model. This novel mRNA, with a comb-like structure and double-stranded ...
Jul 13, 2023
0
11
